In the meantime, I am just patiently awaiting our first approval in the US (or SI announcing the bombshell that FDA will look at a single trial submission for ischemic/diabetic CHF).
@Martin37 .... can you imagine the size of the CHF deal if there is even just a slight indication that the FDA are interested in a stand alone AA submission for the ischemic/diabetic cohort of the CHF Phase 3 DREAM Trial for Rexlemestrocel-L ?
Based on this previous $350 million Cephalon deal 12 years ago and the extensive new data for Rexlemestrocel-L available now to a prospective partner the mind boggles what sort of deal 'could' unfold .... and let's face it, MESO didn't set up the $180 million ADR Filing in the USA last year for fun - just sayin'
GLTAH
https://www.genengnews.com/topics/t...-commercialize-mesoblast-stem-cell-therapies/
Cephalon Shells Out $350M to Commercialize Mesoblast Stem Cell Therapies
December 8, 2010
https://bit.ly/39NcupC]
CHF Accelerated Approval !, page-107
-
- There are more pages in this discussion • 38 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
99.0¢ |
Change
0.010(1.02%) |
Mkt cap ! $1.130B | |||
| Open | High | Low | Value | Volume |
| 99.5¢ | $1.02 | 98.5¢ | $5.507M | 5.501M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 9996 | 99.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 99.5¢ | 18069 | 3 |
View Market Depth
| Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
| MSB (ASX) Chart |